# Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

> **NCT00507741** · PHASE2 · COMPLETED · sponsor: **Endocyte** · enrollment: 49 (actual)

## Conditions studied

- Ovarian Cancer
- Endometrial Cancer

## Interventions

- **DRUG:** Vintafolide
- **DRUG:** Ertafolide

## Key facts

- **NCT ID:** NCT00507741
- **Lead sponsor:** Endocyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2015-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00507741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00507741, "Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00507741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*